BioWorld MedTech

Aug. 16, 2018

Capillary Biomedical closes $2.9M seed funding

Irvine, Calif.-based Capillary Biomedical Inc. (CapBio), which is looking to combat failure points with current infusion sets, raised $2.9 million in a series seed funding led by the Cove Fund. Read More

Device makers wary of FDA's view of economics of HUDs

FDA gives first-time nod to consumer app for preventing pregnancy

Nanotech opens potential for small, accurate, cheap and fast portable diagnostics

Mutation burden predicts benefit of PD-1-treated NSCLC

Appointments and advancements

Financings

Daily M&A

Other news to note

Product briefs

Regulatory front

BioWorld MedTech's Orthopedics Extra

Today's news in brief

BioWorld

BioWorld briefs for April 11, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 11, 2025.

FDA clears Dexcom G7 15 Day

BioWorld MedTech

The battle to claim the continuous glucose monitor with the longest wear time continues with Dexcom Inc.’s G7 15 Day continuous glucose monitor gaining U.S. FDA...

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

3D rendering of glucagon-like peptide 1 (GLP-1)

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

BioWorld

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...